Practice Areas

Overview

China Practice, Global Vision
Han Kun is a leading full-service law firm in China. Over the years, Han Kun has been widely recognized as a leader in complex cross-border and domestic transactions.

Culture, Media and Entertainment

Comprehensive understanding of the industry and substantial experience.

Domestic and International Capital Markets

Han Kun is a leading PRC law firm for capital markets and is recognized as an expert in the field.

Energy, Minerals and Environmental Protection

Our team in energy (including traditional energy and new energy), minerals and environmental protection comprises more than ten experienced professionals who are graduates of top law schools both in China and abroad. They are equipped with excellent legal writing skills and are able to conduct negotiations in English, French, and other foreign languages. Our partners all have more than ten years of practice experience, specializing in energy, minerals, environmental protection industries and other related fields.

Life Sciences and Healthcare

Specialized and dedicated team, extensive experience

Mergers and Acquisitions

Han Kun’s mergers and acquisitions practice leads the market in numerous authoritative legal rankings.

Outbound Investment

We represent clients in their overseas equity and asset acquisitions and direct investments.

View All

Professionals

Overview

Precise and Efficient, Professional and Practical
Han Kun has more than 700 professionals located in six offices, in Beijing, Shanghai, Shenzhen, Haikou, Wuhan and Hong Kong. Our lawyers are graduates of top universities and have extensive experience as counsel to both Chinese and foreign clients in complex cross-border transactions.

Han Kun Information

Overview

Legal Mind, Business Sense
Han Kun specializes in a full range of practice areas. Combined with cutting-edge practical experience, our professionals provide clients with timely interpretation of legislative trends, legal practices, and hot legal issues.

News

Insights

Publications

Newsletters

About Han Kun

Overview

We Defend Reason, Full of Passion
Han Kun has always been committed to providing clients with legal services that efficiently and practically solve their complex legal problems in a rapidly evolving legal environment. Our network of offices in Beijing, Shanghai, Shenzhen, Hong Kong, Haikou, Wuhan, Singapore and New York City provide seamless, diversified professional legal services across localities and regions to help our clients achieve their objectives and to continually meet new challenges.

Awards and Honors

Social Responsibility

Alumni

Join Us

Overview

Inclusive and People-oriented
Han Kun has a high-quality team of lawyers and offers compensation packages that are highly competitive in the market. Our offices are all located in first-class office buildings and boast superior office environments. We promote harmonious interpersonal relationships, an easy-going work environment, and a people-oriented corporate culture. We look forward to you joining us!

Experienced

Campus Recruitment

Overview

We look forward to working with you.
Han Kun imparts excellence and pursues brilliance-we are legal counsel you can count on at any time.

Return

Han Kun represents QL Biopharm in establishing collaboration with Tonghua Dongbao on its GLP-1 Semaglutide Injection product

2024-05-08

Recently, Beijing QL Biopharmaceutical Co., Ltd. ("QL Biopharm") and Tonghua Dongbao Pharmaceutical Co., Ltd. ("Tonghua Dongbao") entered into a collaboration agreement, according to which Tonghua Dongbao will obtain exclusive commercialization rights in the Chinese mainland for QL Biopharm's GLP-1 product, Semaglutide Injection (indication: glycemic control in adult patients with type 2 diabetes). In addition, the two parties will collaborate on developing the product in overseas markets.

In recent years, GLP-1 products have demonstrated significant value in the treatment of diabetes and weight management. The GLP-1 product in this collaboration is Semaglutide, a long-acting GLP-1 analogue. The partnership between QL Biopharm and Tonghua Dongbao aims to bring the internationally leading Semaglutide to a larger number of domestic diabetes patients. The collaboration in overseas markets is also an important step in the product's international market strategy, which is further opening up broader overseas opportunities and benefiting patients worldwide.

Han Kun is representing QL Biopharm in its collaboration with Tonghua Dongbao regarding the GLP-1 product. Owing to the firm's extensive experience and profound understanding of the life sciences industry, Han Kun not only provided legal services throughout all stages of the transaction process, such as deal structure design, contract negotiation, and project consummation, but was deeply involved in negotiating commercial terms for the strategic cooperation, which requires a high level of specialized expertise. This project is an excellent example of Han Kun's experience and expertise in the life sciences and healthcare industry.

About QL Biopharm

QL Biopharm focuses on the production of recombinant protein drugs using Escherichia coli, and is committed to the development of innovative biological drugs for the treatment of chronic metabolic diseases (such as diabetes, obesity, NASH, etc.) to improve the quality of life. At present, ten innovative recombinant protein drugs and biosimilars are in current QL Biopharm R&D pipeline. The core members of QL Biopharm's R&D team come from Novo Nordisk and other well-known pharmaceutical companies around the world, and have accumulated rich experience in biopharmaceutical field.